Cargando…
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
SARS-CoV-2 infection and the resulting COVID-19 have afflicted millions of people in an ongoing worldwide pandemic. Safe and effective vaccination is needed urgently to protect not only the general population but also vulnerable subjects such as patients with cancer. Currently approved mRNA-based SA...
Autores principales: | Romano, Emanuela, Pascolo, Steve, Ott, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206178/ https://www.ncbi.nlm.nih.gov/pubmed/34117117 http://dx.doi.org/10.1136/jitc-2021-002932 |
Ejemplares similares
-
Vaccines against COVID-19: Priority to mRNA-Based Formulations
por: Pascolo, Steve
Publicado: (2021) -
Approved mRNA Vaccines for SARS-CoV-2
por: Faiman, Beth
Publicado: (2021) -
Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023) -
SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome
por: Takanohashi, Asako, et al.
Publicado: (2022) -
Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)